Skip to main content
. 2022 Dec 6;13:1015355. doi: 10.3389/fimmu.2022.1015355

Figure 5.

Figure 5

Schematic illustrating the metabolism of the oral inhibitor VV116. VV116 is an orally administered tri-isobutyrate ester prodrug of GS-441524. After intestinal absorption, VV116 is efficiently converted by cellular enzymes to the plasma metabolite VV116-N1 (median Tmax 1.0–2.5 h), which undergoes three phosphorylation events to yield the active form, VV116-NTP.